Against Another Nonspecific Marker of Perfusion.
作者信息
Siuba Matthew T, Farkas Joshua D
机构信息
Cleveland ClinicCleveland, Ohioand.
University of VermontBurlington, Vermont.
出版信息
Ann Am Thorac Soc. 2019 Oct;16(10):1334-1335. doi: 10.1513/AnnalsATS.201905-415LE.
Abstract
摘要
相似文献
1
Against Another Nonspecific Marker of Perfusion.
Ann Am Thorac Soc. 2019 Oct;16(10):1334-1335. doi: 10.1513/AnnalsATS.201905-415LE.
2
Reply: Against Another Nonspecific Marker of Perfusion.
Ann Am Thorac Soc. 2019 Oct;16(10):1337-1338. doi: 10.1513/AnnalsATS.201906-484LE.
3
Reply: Against Another Nonspecific Marker of Perfusion and Troponin in Sepsis.
Ann Am Thorac Soc. 2019 Oct;16(10):1336-1337. doi: 10.1513/AnnalsATS.201907-516LE.
4
Plasma Ferritin as Marker of Macrophage Activation-Like Syndrome in Critically Ill Patients With Community-Acquired Pneumonia.
Crit Care Med. 2021 Nov 1;49(11):1901-1911. doi: 10.1097/CCM.0000000000005072.
5
Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness.
J Thromb Thrombolysis. 2013 Feb;35(2):147-54. doi: 10.1007/s11239-012-0833-4.
6
Severe community-acquired pneumonia (CAP) and the Infectious Diseases Society of America/American Thoracic Society CAP guidelines prediction rule: validated or not.
Clin Infect Dis. 2009 Feb 15;48(4):386-8. doi: 10.1086/596308.
7
Critical illness-related corticosteroid insufficiency and community-acquired pneumonia: back to the future!
Eur Respir J. 2008 Jun;31(6):1150-2. doi: 10.1183/09031936.00040908.
8
[Xuebijing injection versus placebo for critically ill patients with severe community-acquired pneumonia: a randomized controlled trial: research results and clinical value].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Oct;31(10):1199-1203. doi: 10.3760/cma.j.issn.2095-4352.2019.10.004.
9
Outcomes of Critically Ill Very Old Patients With Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome.
Arch Bronconeumol. 2022 Jun;58(6):520-522. doi: 10.1016/j.arbres.2021.05.027. Epub 2021 Jun 18.
10
Decision rules and pneumonia: What are we "predicting," and for whom?
Am J Respir Crit Care Med. 2006 Dec 1;174(11):1169-70. doi: 10.1164/rccm.200609-1389ED.
引用本文的文献
1
Variation in Troponin I Measurement and the Cardiovascular Management Approach Following Elevated Troponin I Among Critically Ill Patients With Sepsis.
Crit Care Explor. 2023 Jan 10;5(1):e0842. doi: 10.1097/CCE.0000000000000842. eCollection 2023 Jan.
2
Identifying Survivors of Sepsis at Risk for Adverse Cardiovascular Outcomes.
Am J Respir Crit Care Med. 2021 Sep 1;204(5):500-501. doi: 10.1164/rccm.202105-1322ED.
3
Reply: Against Another Nonspecific Marker of Perfusion and Troponin in Sepsis.
Ann Am Thorac Soc. 2019 Oct;16(10):1336-1337. doi: 10.1513/AnnalsATS.201907-516LE.
4
Reply: Against Another Nonspecific Marker of Perfusion.
Ann Am Thorac Soc. 2019 Oct;16(10):1337-1338. doi: 10.1513/AnnalsATS.201906-484LE.
本文引用的文献
1
Troponin I: A New Marker of Sepsis-induced Hypoperfusion?
Ann Am Thorac Soc. 2019 May;16(5):552-553. doi: 10.1513/AnnalsATS.201902-099ED.
2
Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial.
JAMA. 2019 Feb 19;321(7):654-664. doi: 10.1001/jama.2019.0071.
3
Myocardial Injury in Critically Ill Patients with Community-acquired Pneumonia. A Cohort Study.
Ann Am Thorac Soc. 2019 May;16(5):606-612. doi: 10.1513/AnnalsATS.201804-286OC.
4
Fourth universal definition of myocardial infarction (2018).
Eur Heart J. 2019 Jan 14;40(3):237-269. doi: 10.1093/eurheartj/ehy462.
5
Elevated cardiac troponin measurements in critically ill patients.
Arch Intern Med. 2006;166(22):2446-54. doi: 10.1001/archinte.166.22.2446.
Zotero 插件